New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 17, 2012
07:45 EDTVIVOMeridian Bioscience price target raised to $24 from $22 at RW Baird
Baird raised its price target on Meridian Bioscience following meeting with management. The firm believes investors sentiment is low but feels comfortable with guidance and management strategy for growth. Shares are Outperform rated.
News For VIVO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 23, 2015
07:34 EDTVIVOMeridian Bioscience still sees FY15 EPS 85c-91c, consensus 86c
Subscribe for More Information
07:34 EDTVIVOMeridian Bioscience reaffirms FY15 guidance
07:33 EDTVIVOMeridian Bioscience reports Q2 EPS 24c, consensus 24c
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use